Observational Study of Safety of NovoMix® 30 Treatment for Type 2 Diabetes
NCT01486875
·
clinicaltrials.gov ↗
COMPLETED
Status
1155
Enrollment
INDUSTRY
Sponsor class
Conditions
Diabetes
Diabetes Mellitus, Type 2
Interventions
DRUG:
biphasic insulin aspart 30
Sponsor
Novo Nordisk A/S